Dendritic cell vaccination against ovarian cancer–tipping the Treg/TH17 balance to therapeutic advantage?
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2011-01-28 / Expert Opin Biol Ther 2011 Apr;11(4):441-5Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen
/in Dendritic Cells, International Publications /von 2011-01-18 / Am. J. Reprod. Immunol. 2011 Jun;65(6):597-609[Study on the specific immunity induced by dendritic cell vaccine loading allogenic microvascular endothelial cell bEnd.3 antigen against U14 cervical cancer cell in mice]
/in Cervical Cancer, Dendritic Cells, International Publications /von 2011-01-01 / Zhonghua Fu Chan Ke Za Zhi 2011 Jan;46(1):52-7Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2011-01-01 / J. Immunother. 2011 Jan;34(1):100-6Sipuleucel-T: in metastatic castration-resistant prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-01-01 / Drugs 2011 Jan;71(1):101-8New perspectives in glioma immunotherapy
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-01-01 / Curr. Pharm. Des. 2011;17(23):2439-67Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy
/in Dendritic Cells, International Publications /von 2010-12-20 / Clin. Dev. Immunol. 2010;2010:565643Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2010-12-13 / J. Clin. Oncol. 2011 Jan;29(3):330-6Guiding the „misguided“ – functional conditioning of dendritic cells for the DC-based immunotherapy against tumours
/in Dendritic Cells, International Publications /von 2010-12-09 / Eur. J. Immunol. 2011 Jan;41(1):18-25IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de